Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
-
Market Cap
11.98B
Enterprise Value
15.60B
Income
476.91M
Sales
7.12B
Book/sh
10.96
Cash/sh
4.91
Employees
63388
IPO
Nov 18, 1996
P/E
25.35
Forward P/E
15.78
PEG
1.78
P/S
1.68
P/B
2.17
P/C
4.85
P/FCF
15.59
EV/EBITDA
9.42
EV/Sales
2.19
Quick Ratio
0.98
Current Ratio
1.06
Debt/Eq
1.10
LT Debt/Eq
0.72
Option/Short
Yes / Yes
EPS (ttm)
0.94
EPS next Y
1.51
EPS next Q
0.65
EPS this Y
8.62%
EPS next Y
7.75%
EPS next 5Y
8.87%
EPS past 3/5Y
9.35% 7.73%
Sales past 3/5Y
14.81% 14.12%
EPS Y/Y TTM
43.13%
Sales Y/Y TTM
2.92%
EPS Q/Q
3.18%
Sales Q/Q
5.76%
Insider Own
0.00%
Insider Trans
-
Inst Own
16.75%
Inst Trans
3.63%
ROA
2.23%
ROE
5.96%
ROIC
5.02%
Gross Margin
13.95%
Oper. Margin
13.95%
Profit Margin
6.70%
SMA20
8.64%
SMA50
8.84%
SMA200
-15.80%
Trades
Shs Outstand
503.25M
Shs Float
502.93M
52W High
34.67 -31.26%
52W Low
19.50 22.24%
Volatility
1.60% 1.61%
ATR (14)
0.47
RSI (14)
69.27
Beta
1.00
Rel Volume
0.01
Avg Volume
1.77M
Volume
1,003
Perf Week
4.56%
Perf Month
19.45%
Perf Quarter
-2.58%
Perf Half Y
-30.32%
Perf YTD
-19.11%
Perf Year
-13.06%
Perf 3Y
-12.84%
Perf 5Y
-42.30%
Perf 10Y
68.41%
Prev Close
23.57
Price
23.83
Change %
1.10%
Consensus
Buy
Avg. Price Target
$29.10
Implied Upside
+22.1%
Analysts12incl. previous ratings
Rating Distribution5 Buy · 7 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 05, 2026Upgrade
SF logoSStifel
Hold → Buy
Sep 29, 2026Downgrade
MS logoMMorgan Stanley
Overweight → Equal-Weight
Jul 31, 2026Downgrade
BBNP Paribas Exane
Outperform → Neutral$26.70+12.0%
Jul 07, 2026Upgrade
GS logoGGoldman
Neutral → Buy
Mar 12, 2026Upgrade
UBS logoUUBS
Neutral → Buy
Mar 11, 2026Upgrade
RRothschild & Co Redburn
Sell → Neutral
Feb 24, 2026Downgrade
DB logoDDeutsche Bank
Buy → Hold
Jan 06, 2026Upgrade
MS logoMMorgan Stanley
Equal-Weight → Overweight
Dec 18, 2025Upgrade
BAC logoBBofA Securities
Neutral → Buy$34+42.7%
Oct 07, 2025Upgrade
BBernstein
Underperform → Outperform
Rentokil Initial Plc engages in the provision of business support services. The firm's products and services protect people from pest-borne disease and the risks of poor hygiene. It operates through the following geographical segments: North America, Europe, UK and Sub-Saharan Africa, Asia and MENAT, and Pacific. The company was founded by Harold Maxwell-Lefroy on September 24, 1924 and is headquartered in Crawley, the United Kingdom.
CFO & DirectorMr. Paul Russell Edgecliffe-Johnson
CEO & Executive DirectorMr. Michael A. Duffy Jr.
Chief Information OfficerMr. Mark Purcell